国产首款集成一体式CoreVascu 人工血管大湾区启动即入组

Group 1 - The first integrated CoreVascu artificial blood vessel clinical trial in China has officially launched at the South China Hospital of Shenzhen University, marking a significant milestone for the product [1] - The first patient has been successfully implanted, indicating an efficient start to the clinical trial process [1] - The CoreVascu artificial blood vessel is a collaborative development between Sanxin Medical and Zhejiang University of Science and Technology, breaking the long-standing foreign monopoly in the small-diameter artificial blood vessel market [1]